These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 553752

  • 21. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
    Peduzzi L, Cozzi E.
    Minerva Med; 1983 Feb 18; 74(6):249-54. PubMed ID: 6338419
    [Abstract] [Full Text] [Related]

  • 22. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J.
    Sem Hop Ther; 1973 Jan 18; 49(1):31-6. PubMed ID: 4712022
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H, Jaillard J.
    Lille Med; 1968 Jan 18; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract] [Full Text] [Related]

  • 24. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A, Carletta C.
    Clin Ter; 1979 Oct 15; 91(1):57-65. PubMed ID: 397871
    [No Abstract] [Full Text] [Related]

  • 25. Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
    Giorcelli G, Vacha G, Icardi GP.
    Proc Eur Dial Transplant Assoc; 1980 Oct 15; 17():367-71. PubMed ID: 7243794
    [Abstract] [Full Text] [Related]

  • 26. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N.
    Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978
    [No Abstract] [Full Text] [Related]

  • 27. [Drugs in hyperlipidemia].
    Stuyt PM.
    Ned Tijdschr Geneeskd; 1987 Sep 05; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract] [Full Text] [Related]

  • 28. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF.
    Postgrad Med J; 1975 Sep 05; 51(8):63-5. PubMed ID: 768949
    [No Abstract] [Full Text] [Related]

  • 29. [Relationship between the manifestation of diabetes and the treatment of hyperlipemia].
    Vogelberg KH.
    Verh Dtsch Ges Inn Med; 1978 Sep 05; (84):1178-81. PubMed ID: 741921
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Pharmacological treatment of primary hyperlipoproteinemia].
    Ciświcka-Sznajderman M.
    Pol Tyg Lek; 1976 Feb 16; 31(7):289-91. PubMed ID: 768941
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Drug therapy of dyslipidemias].
    Lenzi S.
    Minerva Med; 1975 Oct 06; 66(66):3479-82. PubMed ID: 1178140
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980 Oct 06; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H, Kolenda KD.
    Med Klin; 1976 Mar 19; 71(12):513-7. PubMed ID: 1263999
    [No Abstract] [Full Text] [Related]

  • 40. Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
    Duncan GG, Elliott FA, Duncan TG, Schatanoff J.
    Trans Am Clin Climatol Assoc; 1968 Mar 19; 79():216-28. PubMed ID: 5760587
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.